ESML logo

ESMLiShares ESG Aware MSCI USA Small-Cap ETF

$52.28
$1.45
(2.70%)
Today
Closed $52.28
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Vol71,191.00
52W High$53.90
52W Low$39.79
News
all
press releases
News Placeholder
MLTX Stock Garners Retail Attention On Buyout Speculation, Positive Skin Condition Trial Data
A Stocktwits user highlighted optimism for a buyout for MoonLake, highlighting other recent mergers and acquisitions in the pharma industry, such as Biogen’s buyout of Apellis.
Stocktwits
News Placeholder
MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event
Some Stocktwits users voiced optimism for the inflammation-drug maker getting acquired by pharma giant Merck.
Stocktwits
News Placeholder
MLTX Stock Extends Rally As FDA Feedback Spurs Bullish Brokerage Action – Retail Speculates On Potential M&A Conversations
BTIG upgraded MoonLake Immunotherapeutics to ‘Buy’ from ‘Neutral’ after the FDA said the company could show the effectiveness of Sonelokimab without additional HS trials.
Stocktwits
News Placeholder
Why Did MLTX Stock Jump 45% In Pre-Market Today?
The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.
Stocktwits
<
...
1
>

Advertisement|Remove ads.